0001371285-24-000265.txt : 20240827 0001371285-24-000265.hdr.sgml : 20240827 20240827193914 ACCESSION NUMBER: 0001371285-24-000265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240825 FILED AS OF DATE: 20240827 DATE AS OF CHANGE: 20240827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEINRAUCH STEVE CENTRAL INDEX KEY: 0001968590 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36537 FILM NUMBER: 241250638 MAIL ADDRESS: STREET 1: 6100 4TH AVENUE SOUTH STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRUPANION, INC. CENTRAL INDEX KEY: 0001371285 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6100 4TH AVENUE SOUTH STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98108 BUSINESS PHONE: 888-733-2685 MAIL ADDRESS: STREET 1: 6100 4TH AVENUE SOUTH STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98108 FORMER COMPANY: FORMER CONFORMED NAME: TRUPANION INC. DATE OF NAME CHANGE: 20131114 FORMER COMPANY: FORMER CONFORMED NAME: VETINSURANCE INTERNATIONAL INC DATE OF NAME CHANGE: 20060802 4 1 wk-form4_1724801948.xml FORM 4 X0508 4 2024-08-25 0 0001371285 TRUPANION, INC. TRUP 0001968590 WEINRAUCH STEVE 6100 4TH AVENUE S SUITE 200 SEATTLE WA 98108 0 1 0 0 EVP, North Am & Vet Strategy 0 Common Stock 2024-08-25 4 M 0 41 A 58546 D Common Stock 2024-08-25 4 F 0 9 46.63 D 58537 D Common Stock 2024-08-25 4 M 0 64 A 58601 D Common Stock 2024-08-25 4 F 0 15 46.63 D 58586 D Common Stock 2024-08-25 4 M 0 1105 A 59691 D Common Stock 2024-08-25 4 F 0 269 46.63 D 59422 D Common Stock 2024-08-25 4 M 0 1414 A 60836 D Common Stock 2024-08-25 4 F 0 344 46.63 D 60492 D Common Stock 2024-08-25 4 M 0 531 A 61023 D Common Stock 2024-08-25 4 F 0 129 46.63 D 60894 D Restricted Stock Unit (RSU) 2024-08-25 4 M 0 41 0 D 2027-02-25 Common Stock 41 405 D Restricted Stock Unit (RSU) 2024-08-25 4 M 0 64 0 D 2025-02-25 Common Stock 64 129 D Restricted Stock Unit (RSU) 2024-08-25 4 M 0 1105 0 D 2025-02-25 Common Stock 1105 2211 D Restricted Stock Unit (RSU) 2024-08-25 4 M 0 1414 0 D 2027-08-25 Common Stock 1414 4241 D Restricted Stock Unit (RSU) 2024-08-25 4 M 0 531 0 D 2026-02-25 Common Stock 531 3184 D Restricted stock units convert into common stock on a one-for-one basis. This Form 4 discloses the shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting of the restricted stock units, and does not represent a sale by the reporting person. On February 27, 2023, the reporting person was granted 649 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2024, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date. On February 22, 2021, the reporting person was granted 1,028 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2022, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date. On February 22, 2021, the reporting person was granted 17,685 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2022, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date. On August 14, 2023, the reporting person was granted 5,655 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/4th of the total shares on August 25, 2024, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date. On February 28, 2022, the reporting person was granted 8,490 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2023, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date. /s/ Christina Poler as attorney-in-fact for Steve Weinrauch 2024-08-27